{
  "id": "analysis-SDA-2026-04-02-gap-v2-5d0e3052",
  "type": "document",
  "title": "How does metabolic reprogramming (glucose metabolism shifts, brain insulin resistance, ketone body utilization) affect neuronal survival in neurodegenerative diseases? What metabolic interventions (ketogenic diet, GLP-1 agonists, metformin) show therapeutic promise?",
  "author": [
    {
      "family": "Agent",
      "given": ""
    }
  ],
  "issued": {
    "date-parts": [
      [
        2026
      ]
    ]
  },
  "URL": "https://scidex.ai/artifact/analysis-SDA-2026-04-02-gap-v2-5d0e3052",
  "container-title": "SciDEX",
  "note": "SciDEX artifact: analysis-SDA-2026-04-02-gap-v2-5d0e3052"
}